Bando Chemical’s consolidated sales for the fiscal year ending March 2026 are 119,257 million yen, a 3.2% increase from the previous fiscal year. Net income rose by 264.2% to 10,568 million yen, and earnings per share increased to 256.49 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5195","jir_company_name":"Bando Chemical Industries Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/5195-20260514-04.pdf","jir_short_summary":"Bando Chemical's consolidated sales for the fiscal year ending March 2026 are 119,257 million yen, a 3.2% increase from the previous fiscal year. Net income rose by 264.2% to 10,568 million yen, and earnings per share increased to 256.49 yen.","jir_summary":"### Financial Highlights\nBando Chemical's consolidated sales for the fiscal year ending March 2026 reached 119,257 million yen, representing a 3.2% increase from the previous year. Net income surged by 264.2% to 10,568 million yen, with earnings per share rising to 256.49 yen. Operating income and pre-tax income also increased, notably driven by insurance claim receipts and deferred tax asset recognition.\n\n### Future Outlook and Investor Implications\nThis earnings report features significant net income growth driven by insurance claim receipts and tax asset increases. Moving forward, the company aims to maintain a stable earnings base while focusing on business strategy execution and risk management. Investors should pay attention to the sustainability of growth factors and future strategic initiatives.","jir_financial_highlights":"Sales Revenue: 119,257 million yen (+3.2%)\nCore Operating Income: 9,551 million yen (unknown)\nOperating Income: 12,073 million yen (unknown)\nPre-tax Income for the Period: 12,646 million yen (unknown)\nNet Income Attributable to Owners of Parent: 10,568 million yen (264.2%)\nEarnings Per Share for the Period: 256.49 yen (YoY +220.17 yen)","jir_category":"","jir_hashtags":"#BandoChemical, #IRResults, #JapanStocks","jir_key_figures":"Sales Revenue: 119,257 million yen (YoY +3.2%)\nNet Income Attributable to Owners of Parent: 10,568 million yen (YoY +264.2%)\nEarnings Per Share for the Period: 256.49 yen (YoY +220.17 yen)","jir_meta_title":"\u3010Bando Chemical\u3011 Fiscal Year Ending March 2026 Results | Sales of 119.2 billion yen (+3.2%)","jir_meta_description":"Detailed analysis of Bando Chemical\u2019s fiscal year ending March 2026 consolidated results. Sales of 119,257 million yen, net income of 10,568 million yen, and earnings per share of 256.49 yen, showing growth in revenue and profit.","jir_og_title":"\u3010Bando Chemical\u3011 Fiscal Year Ending March 2026 Results | Sales of 119.2 billion yen (+3.2%)","jir_og_description":"Overview of Bando Chemical's fiscal year ending March 2026 results. Both sales and net income increased, with future prospects attracting attention.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16686,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-50138","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n